08-108: DENUFOSOL TETRASODIUM INHALATOIN SOLUTION IN MILD CF LUNG DISEASE

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 这项研究旨在评估60毫克剂量的德努福索(INS37217)雾化溶液与安慰剂在24周内每天3次给药的安全性和有效性。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study aims to evaluate the safety and efficacy of a 60 mg dose of Denufosol (INS37217) Inhalation Solution compared to a placebo administered 3 times daily over 24 weeks in subjects with CF.